NM_002755.3(MAP2K1):c.171G>C (p.Lys57Asn) AND Lung adenocarcinoma

Clinical significance:Likely pathogenic (Last evaluated: May 31, 2016)

Review status:(0/4) 0 stars out of maximum of 4 stars

no assertion criteria provided

Based on:
1 submission [Details]
Record status:
current
Accession:
RCV000437917.1

Allele description [Variation Report for NM_002755.3(MAP2K1):c.171G>C (p.Lys57Asn)]

NM_002755.3(MAP2K1):c.171G>C (p.Lys57Asn)

Gene:
MAP2K1:mitogen-activated protein kinase kinase 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
15q22.31
Genomic location:
Preferred name:
NM_002755.3(MAP2K1):c.171G>C (p.Lys57Asn)
HGVS:
  • NC_000015.10:g.66435117G>C
  • NG_008305.1:g.53245G>C
  • NM_002755.3:c.171G>C
  • NP_002746.1:p.Lys57Asn
  • LRG_725t1:c.171G>C
  • LRG_725:g.53245G>C
  • LRG_725p1:p.Lys57Asn
  • NC_000015.9:g.66727455G>C
Protein change:
K57N
Links:
dbSNP: rs869025608
NCBI 1000 Genomes Browser:
rs869025608
Molecular consequence:
  • NM_002755.3:c.171G>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Lung adenocarcinoma
Synonyms:
Adenocarcinoma of lung; Adenocarcinoma of lung, somatic
Identifiers:
MONDO: MONDO:0005061; MeSH: D000077192; MedGen: C0152013; Human Phenotype Ontology: HP:0030078

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000505216Database of Curated Mutations (DoCM)no assertion criteria providedLikely pathogenic
(May 31, 2016)
somaticliterature only

PubMed (2)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedsomaticyesnot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.

Chang MT, Asthana S, Gao SP, Lee BH, Chapman JS, Kandoth C, Gao J, Socci ND, Solit DB, Olshen AB, Schultz N, Taylor BS.

Nat Biotechnol. 2016 Feb;34(2):155-63. doi: 10.1038/nbt.3391. Epub 2015 Nov 30.

PubMed [citation]
PMID:
26619011
PMCID:
PMC4744099

Prospective enterprise-level molecular genotyping of a cohort of cancer patients.

MacConaill LE, Garcia E, Shivdasani P, Ducar M, Adusumilli R, Breneiser M, Byrne M, Chung L, Conneely J, Crosby L, Garraway LA, Gong X, Hahn WC, Hatton C, Kantoff PW, Kluk M, Kuo F, Jia Y, Joshi R, Longtine J, Manning A, Palescandolo E, et al.

J Mol Diagn. 2014 Nov;16(6):660-72. doi: 10.1016/j.jmoldx.2014.06.004. Epub 2014 Aug 23.

PubMed [citation]
PMID:
25157968
PMCID:
PMC4210463

Details of each submission

From Database of Curated Mutations (DoCM), SCV000505216.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (2)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1somaticyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 7, 2021

Support Center